查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1387274

全球 RNA 分析/轉錄組學市場：趨勢、預測和競爭分析（~2030 年）

RNA Analysis/Transcriptomics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

RNA 分析/轉錄組學的趨勢和預測

預計2030年，全球RNA分析/轉錄組學市場規模將達到約123億美元，2024年至2030年年複合成長率為10.5%。該市場的主要驅動力是個人化醫療需求的不斷成長以及製藥和生物技術行業的持續成長。全球RNA分析/轉錄組市場的未來前景廣闊，在政府機構/學術中心、製藥/生物技術、醫院/診所以及合約藥物委外研發機構都有商機。

RNA 分析/轉錄組學市場洞察

根據 Lucintel 的預測，由於基於標靶序列的應用方法越來越受歡迎，藥物研發預計將在預測期內實現最高成長。

由於人們越來越偏好基於結構的藥物設計以及該地區大型製藥企業和生物製藥公司的存在，北美仍然是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球RNA 分析/轉錄組學市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢與預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球RNA分析/轉錄組學市場趨勢（2018-2023）與預測（2024-2030）
  • 全球 RNA 分析/轉錄組學市場：依產品類型
    • 消耗品
    • 裝置
    • 軟體
    • 服務
  • 全球 RNA 分析/轉錄組學市場：按技術分類
    • 即時螢光定量PCR (qPCR)
    • 微陣列
    • 順序
    • 其他
  • 全球 RNA 分析/轉錄組學市場：按應用分類
    • 藥物研發
    • 診斷/疾病分析
    • 其他
  • 全球 RNA 分析/轉錄組學市場：依最終用途分類
    • 政府機構/學術中心
    • 製藥/生物技術
    • 醫院/診所
    • 藥品委外研發機構
    • 其他

第4章 市場趨勢與預測分析：按地區（2018-2030）

  • 全球 RNA 分析/轉錄組學市場：按地區
  • 北美RNA分析/轉錄組學市場
  • 歐洲RNA分析/轉錄組學市場
  • 亞太地區RNA分析/轉錄組市場
  • 其他地區RNA分析/轉錄組市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球 RNA 分析/轉錄組學市場成長機會
    • 全球 RNA 分析/轉錄組學市場成長機會（按技術）
    • 全球 RNA 分析/轉錄組學市場成長機會（按應用）
    • 全球 RNA 分析/轉錄組學市場成長機會（依最終用途）
    • 全球 RNA 分析/轉錄組學市場成長機會（按地區）
  • 全球RNA分析/轉錄組學市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球RNA分析/轉錄組學市場的產能
    • 全球RNA分析/轉錄組學市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Pacific Bioscience of California
  • Affymetrix
簡介目錄

RNA Analysis/Transcriptomics Trends and Forecast

The future of the global RNA analysis/transcriptomics market looks promising with opportunities in the government institute & academic center, pharmaceutical & biotechnology, hospital & clinic, and contract research organizations markets. The global RNA analysis/transcriptomics market is expected to reach an estimated $12.3 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are increasing demand for personalized medicine and continual growth of pharmaceutical & biological industries.

A more than 150-page report is developed to help in your business decisions.

RNA Analysis/Transcriptomics by Segment

The study includes a forecast for the global RNA analysis/transcriptomics by product type, technology, application, end use, and region.

RNA Analysis/Transcriptomics Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Consumables
  • Instruments
  • Software
  • Services

RNA Analysis/Transcriptomics Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Real Time-PCR (qPCR)
  • Microarray
  • Sequencing
  • Others

RNA Analysis/Transcriptomics Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Drug Discovery
  • Diagnostics & Disease Profiling
  • Others

RNA Analysis/Transcriptomics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Government Institutes & Academic Centers
  • Pharmaceutical & Biotechnology
  • Hospitals & Clinics
  • Contract Research Organizations (CROs)
  • Others

RNA Analysis/Transcriptomics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of RNA Analysis/Transcriptomics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies RNA analysis/transcriptomics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the RNA analysis/transcriptomics companies profiled in this report include-

  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Pacific Bioscience of California
  • Affymetrix

RNA Analysis/Transcriptomics Market Insights

Lucintel forecasts that drug discovery is expected to witness highest growth over the forecast period due to growing popularity of targeted sequencing-based approaches in this application.

North America will remain the largest region due to growing preference for structure-based drug designs and existence of major pharma and biopharma companies in the region.

Features of the Global RNA Analysis/Transcriptomics Market

Market Size Estimates: RNA analysis/transcriptomics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: RNA analysis/transcriptomics market size by various segments, such as by product type, technology, application, end use, and region in terms of value ($B).

Regional Analysis: RNA analysis/transcriptomics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the RNA analysis/transcriptomics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the RNA analysis/transcriptomics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the RNA analysis/transcriptomics market size?

Answer: The global RNA analysis/transcriptomics market is expected to reach an estimated $12.3 billion by 2030.

Q2. What is the growth forecast for RNA analysis/transcriptomics market?

Answer: The global RNA analysis/transcriptomics market is expected to grow with a CAGR of 10.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the RNA analysis/transcriptomics market?

Answer: The major drivers for this market are increasing demand for personalized medicine and continual growth of pharmaceutical & biological industries.

Q4. What are the major segments for RNA analysis/transcriptomics market?

Answer: The future of the RNA analysis/transcriptomics market looks promising with opportunities in the government institute & academic center, pharmaceutical & biotechnology, hospital & clinic, and contract research organizations markets.

Q5. Who are the key RNA analysis/transcriptomics market companies?

Answer: Some of the key RNA analysis/transcriptomics companies are as follows:

  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Illumina
  • QIAGEN
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Merck KGaA
  • Bio-Rad Laboratories
  • Pacific Bioscience of California
  • Affymetrix

Q6. Which RNA analysis/transcriptomics market segment will be the largest in future?

Answer: Lucintel forecasts that drug discovery is expected to witness highest growth over the forecast period due to growing popularity of targeted sequencing-based approaches in this application.

Q7. In RNA analysis/transcriptomics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing preference for structure-based drug designs and existence of major pharma and biopharma companies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the RNA analysis/transcriptomics market by product type (consumables, instruments, software, and services), technology (real time-pcr (qPCR), microarray, sequencing, and others), application (drug discovery, diagnostics & disease profiling, and others), end use (government institutes & academic centers, pharmaceutical & biotechnology, hospitals & clinics, contract research organizations (CROs), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global RNA Analysis/Transcriptomics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global RNA Analysis/Transcriptomics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global RNA Analysis/Transcriptomics Market by Product Type
    • 3.3.1: Consumables
    • 3.3.2: Instruments
    • 3.3.3: Software
    • 3.3.4: Services
  • 3.4: Global RNA Analysis/Transcriptomics Market by Technology
    • 3.4.1: Real Time-PCR (qPCR)
    • 3.4.2: Microarray
    • 3.4.3: Sequencing
    • 3.4.4: Others
  • 3.5: Global RNA Analysis/Transcriptomics Market by Application
    • 3.5.1: Drug Discovery
    • 3.5.2: Diagnostics & Disease Profiling
    • 3.5.3: Others
  • 3.6: Global RNA Analysis/Transcriptomics Market by End Use
    • 3.6.1: Government Institutes & Academic Centers
    • 3.6.2: Pharmaceutical & Biotechnology
    • 3.6.3: Hospitals & Clinics
    • 3.6.4: Contract Research Organizations (CROs)
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global RNA Analysis/Transcriptomics Market by Region
  • 4.2: North American RNA Analysis/Transcriptomics Market
    • 4.2.1: North American RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
    • 4.2.2: North American RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others
  • 4.3: European RNA Analysis/Transcriptomics Market
    • 4.3.1: European RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
    • 4.3.2: European RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others
  • 4.4: APAC RNA Analysis/Transcriptomics Market
    • 4.4.1: APAC RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
    • 4.4.2: APAC RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others
  • 4.5: ROW RNA Analysis/Transcriptomics Market
    • 4.5.1: ROW RNA Analysis/Transcriptomics Market by Application: Drug Discovery, Diagnostics & Disease Profiling, and Others
    • 4.5.2: ROW RNA Analysis/Transcriptomics Market by End Use: Government Institutes & Academic Centers, Pharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations (CROs), and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Product Type
    • 6.1.2: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Technology
    • 6.1.3: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Application
    • 6.1.4: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by End Use
    • 6.1.5: Growth Opportunities for the Global RNA Analysis/Transcriptomics Market by Region
  • 6.2: Emerging Trends in the Global RNA Analysis/Transcriptomics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global RNA Analysis/Transcriptomics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global RNA Analysis/Transcriptomics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Agilent Technologies
  • 7.2: F. Hoffmann-La Roche
  • 7.3: Illumina
  • 7.4: QIAGEN
  • 7.5: Thermo Fisher Scientific
  • 7.6: Eurofins Scientific
  • 7.7: Merck KGaA
  • 7.8: Bio-Rad Laboratories
  • 7.9: Pacific Bioscience of California
  • 7.10: Affymetrix